Session Type
Meeting
Search Results for Opioid
Abstract Number: 152
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: While prescription opioids have a role in treating certain pain conditions, their injudicious use has led to an epidemic with myriad adverse outcomes. We sought to evaluate the association of socioeconomic and racial disparities with healthcare utilization and outcomes in opioid overdose related hospitalizations using National Inpatient Sample (NIS) database from 2012 through 2014. […]
Abstract Number: 163
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: In the inpatient setting, opioids are the most commonly prescribed medication and the 2nd most frequent cause of adverse drug events (ADE). Identifying patients at high risk for ADEs related to narcotics is essential. These ADEs include ileus, altered mental status, and respiratory depression. Obstructive sleep apnea, organ impairment, and other medication use (i.e. […]
Abstract Number: 169
SHM Converge 2021
Background: Naloxone is a medication that reverses opioid overdose in emergency situations and prevents deaths. A group of 55 Eastern Virginia Medical School (EVMS) medical students were trained by REVIVE!, a program that educates on how to recognize and respond to an opioid overdose emergency with the administration of naloxone. We evaluated whether there is […]
Abstract Number: 169
Hospital Medicine 2020, Virtual Competition
Background: Prescription opioids have come under increasing scrutiny in recent years due to the rise in use and misuse which has resulted in significant morbidity and mortality. There have been several efforts by government agencies to address this such as the FDA issuing a Risk Evaluation Mitigation Strategy (REMS) for extended release/long acting (ERLAs) opioids […]
Abstract Number: 174
Hospital Medicine 2020, Virtual Competition
Background: New Mexico has a long-standing history of implementing harm reduction strategies for the prevention of opioid overdose. Most recently, on June 14, 2019, SB221 added language to the New Mexico Pain Relief Act requiring health care providers prescribing opioid analgesics for 5 days or longer to co-prescribe an opioid antagonist along with written information […]
Abstract Number: 180
SHM Converge 2023
Background: Almost three-quarters of hospitals with 50 or more beds have a palliative care program, and the percentage of annual hospital admissions receiving an initial palliative care consultation is more than 5%. Methylnaltrexone (MNTX) is a peripherally acting µ-opioid receptor antagonist indicated for opioid-induced constipation (OIC) in patients with advanced illness who are receiving palliative […]
Abstract Number: 181
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: In utero opioid exposure can result in neonatal abstinence syndrome (NAS). NAS incidence has increased five-fold in the last decade. NAS is a serious condition characterized by central nervous system hyperirritability and autonomic nervous system and gastrointestinal tract dysfunction. Newborns with NAS may have several potential complications, may require pharmacological management, have increased hospital […]
Abstract Number: 194
SHM Converge 2021
Background: Patients with Substance Use Disorder (SUD) are a nationwide concern. They have significant morbidity, mortality & for several reasons, such as comorbid psychiatric conditions, medication noncompliance, low income or poor access to healthcare services, have an increased risk of hospital readmissions. Processes aimed at reducing readmission rates in this population are important for improving […]
Abstract Number: 207
SHM Converge 2021
Background: Hospitalizations among patients with opioid use disorder (OUD) have skyrocketed in the past 10 years (1). These patients represent an ever-growing portion of the typical hospital medicine census and often have readmission rates greater than expected for their age and other health status. Discharge against medical advice (AMA) is common in this population, and […]
Abstract Number: 209
SHM Converge 2021
Background: Readmission among Inflammatory Bowel Disease (IBD) inpatients is common, as is opioid use. Opioid use for IBD has been associated with an increased risk of infection and death, but inconsistently with readmissions. Increasingly, cannabis is viewed as a potentially safer alternative to opioids, though with limited study of potential adverse outcomes such as hospital […]